期刊文献+

miR-20a海绵载体构建及在白血病细胞株Jurkat中的表达 被引量:4

Construction of miRNA Sponge Targeting miR-20a and Stable Expression in Jurkat Leukemia Cell Line
下载PDF
导出
摘要 本研究构建miR-20a基因的miRNA海绵载体,建立Jurkat-S稳定细胞株,为进一步研究的miR-20a功能及应用干扰技术治疗奠定基础。设计、合成1对含有2个重复针对miR-20a成熟序列第9-12碱基错配的序列,并带有酶切位点,退火后连接到pCDNA3.0-L表达载体上;载体双酶切后再与退火产物连接,重复4次后进行酶切及荧光素酶活性鉴定;亚克隆到慢病毒表达载体,与psPAX2、PMD2G共转染HEK 293T细胞,包装产生慢病毒颗粒并测定病毒滴度,感染Jurkat细胞,建立稳定细胞株;应用实时PCR和Western blot技术分别检测Jurkat-S稳定细胞中P21及E2F1 mRNA和蛋白的表达,并与对照组进行比较。结果表明,成功构建了针对miR-20a基因的海绵载体,病毒滴度为5×107TU/ml;建立了稳定转染的Jurkat-S细胞株。有效干扰验证显示,miR-20a海绵能明显上调P21及E2F1的mRNA及蛋白表达水平,差异有统计学意义(P<0.05)。结论:成功构建miR-20a基因的miRNA海绵载体,建立稳定干扰miR-20a表达的Jurkat-S细胞株。 This study was aimed to construct miRNA sponge targeting miR-20a and to establish a stable cell line Jurkat-S,paving the way for further research on function of miR-20a and application of RNAi in gene therapy.One pair of two-repeated oligonucleotide sequences containing bulged sites that are mispaired opposite miR-20a positions 9-12 was designed and synthesized with enzyme cutting sites.The annealed oligonucleotide fragments were subcloned into pCDNA3.0-L expressing vector.After double-enzyme cutting,the vector was ligated to the annealed oligonucleotide fragments again.Enzyme cutting and luciferase activity assay were performed for identification after four repeats.Then the ligated fragment was subcloned to lentivirus expressing vector.Virus particles were collected after the control or sponge vectors were co-transfected with the psPAX2 packaging plasmid and the envelope plasmid pMD2.G into HEK-293T cells using Lipofectamine2000.The Jurkat cells were transdused with recombinant lentivirus-transdusing units plus 6 μg/ml of Polybrene.Real-time PCR and Western blot were used to detect the mRNA and protein expression of P21 and E2F1 after lentivirus transdusion respectively.As a result,luciferase activity assay demonstrated that the sponge targeting miR-20a was constructed successfully and the virus was packaged in 293T.The titer of virus was 5×107 TU /ml.Stable transfected Jurkat-S cell line was established.As was expected,the mRNA and protein level of P21 and E2F1 was upregulated significantly in Jurkat-S cells.It is concluded that the miR-20a sponge is constructed successfully,and Jurkat-S stable cell line is established,in which the expression of miR-20a is inhibited stably.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第5期1056-1062,共7页 Journal of Experimental Hematology
基金 福建医科大学苗圃基金资助(编号2010MP035) 福建省血液病学重点实验室经费资助(编号2009J1004)
关键词 miR-20a miRNA海绵 JURKAT细胞 miR-20a miRNA sponge Jurkat cell
  • 相关文献

参考文献23

  • 1Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoi- etic lineage differentiation. Science, 2004 ;303 (5654) :83 - 86.
  • 2Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003 ;425 (6956) :415 - 419.
  • 3Georgantas RW, 3rd, Hildreth R, Morisot S, et al. CD34+ hemato- poietic stem-progenitor cell microRNA expression and function: a cir- cuit diagram of differentiation control. Proc Natl Acad Sci USA, 2007 ;104(8) :2750 -2755.
  • 4Ventura A, Young AG, Winslow MM, et al. Targeted deletion re- veals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell, 2008 ; 132 (5) : 875 - 886.
  • 5Ota A, Tagawa H, Karnan S, et al. Identification and characteriza- tion of a novel gene, C13orf25, as a target for 13q31-q32 amplifica- tion in malignant lymphoma. Cancer Res, 2004 ; 64 ( 9 ) : 3087 - 3095.
  • 6Inomata M, Tagawa H, Guo YM, et al. MieroRNA-17-92 down-reg- ulates expression of distinct targets in different B-cell lymphorna sub- types. Blood, 2009; 113(2):396-402.
  • 7杨瑞芳,陈丽娟,李建勇.miR-17-92基因簇与肿瘤[J].中国实验血液学杂志,2010,18(5):1341-1344. 被引量:7
  • 8Guo J, Miao Y, Xiao B, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gas- troenteml Hepatol, 2009 ; 24 (4) :652 - 657.
  • 9Fontana L, Fiori ME, Albini S, et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One, 2008 ; 3 (5) : e2236.
  • 10Hayashita Y, Osada H, Tatematsu Y, et al. A polycistmnic micmR- NA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res, 2005 ; 65 ( 21 ) : 9628 - 9632.

二级参考文献25

  • 1Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993; 75(5) : 843 -854.
  • 2Reinhart BJ, Slack FJ, Basson M, et al. The 21 nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 2000 ; 403 (6772) : 901 - 906.
  • 3Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell, 2008 ; 133 (2) : 217 - 222.
  • 4Tagawa H, Karube K, Tsuzuki S, et al. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci, 2007 ;98(9) : 1482 - 1490.
  • 5Ivanovska I, Ball AS, Diaz RL, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol, 2008 ;28(7) : 2167 -2174.
  • 6Inomata M, Tagawa H, Guo YM, et al. MicroRNA-17-92 down- regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood, 2009 ; 113 (2) : 396 - 402.
  • 7Pichiorri F, Suh SS, Ladetto M, et al. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci USA, 2008 ; 105 (35) : 12885 - 12890.
  • 8Wang Q, Li YC, Wang J, et al. miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc Natl Acad Sci USA, 2008 ; 105 (8) : 2889 - 2894.
  • 9Huntington ND, Labi V, Cumano A, et al. Loss of the proapoptotic BH3-only Bcl-2 family member Bim sustains B lymphopoiesis in the absence of IL-7. Int Immunol, 2009 ; 21 ( 6 ) : 715 -725.
  • 10Ventura A, Young AG, Winslow MM, et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 families of miRNA clusters. Cell, 2008 ; 132 (5) : 875 - 886.

共引文献6

同被引文献22

  • 1BARTEL D P. MicroRNAs : genomics, biogenesis, mecha- nism, and function [ J ]. Ce11,2004,116 (2) : 281-297.
  • 2AMBROS V. The functions of animal microRNAs[ J]. Na- ture ,2004,431 (7006) :350-355.
  • 3EBERT M S, NEILSON J R, SHARP P A. et al. MicroR- NA sponges: compotitive inhibitors of small RNAs in mammalian cells [ J ]. Nat Methods, 2007,4 ( 9 ) : 721- 726.
  • 4BAK R O, HOLLENSEN A K, MIKKELSEN J G. Manag- ing microRNAs with vector-encoded decoy-type inhibitors [J]. Mol Ther,2013,21 (8) :1478-1485.
  • 5FRANCO-ZORRILLA J M, VALLI A, TODESCO M, et al. Targetmimicry provides a new mechanism for regula- tion of microRNA activity [ J ]. Nat Genet,2007,39 : 1033- 1037.
  • 6CARE A, CATALUCCI D, FELICETrI F, et al. MicroR- NA-133 controls cardiac hypertrophy[ J]. Nat Med,2007, 13:613-618.
  • 7GENTNER B,SCHIRA G,GIUSTACCH/NI A,et al. Stable knockdown of microRNA in vivo by lentiviral vectors [ J ]. Nat Methods,2009,6:63-66.
  • 8SAYED D, RANE S, LYPOWY J, et al. MicroRNA-21 tar- gets sprouty2 and promotes cellular outgrowths [ J ]. Mol Biol Cell,2008,19:3272-3282.
  • 9KLUIVER J, GIBCUS J H, HET'FINGA C, et al. Rapid Generation of microRNA sponges for microRNA inhibition[J ]. PLoS One, 2012,7 ( 1 ) : e29275.
  • 10HARAGUCHI T, OZAKI Y, IBA H. Vectors expressing ef- ficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells [ J ]. Nu- cleic Acids Res ,2009,37 (6) : e43.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部